UCSF

ZINC00004413

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 18 Yes

Other Names:

(1S)-1-(3-{[ethyl(methyl)carbamoyl]oxy}phenyl)-N,N-dimethylethanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate; SDZ-ENA 713; rivastigmine hydrogen tartrate

(2S,3S)-2,3-Dihydroxysuccinic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (1:1)

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; 3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; C14H22N2O2; Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester; Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)e

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; Rivastigmine; m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

stigmine

123441-03-2

123441-03-2; C11766; Rivastigmine

123441-03-2; D03822; Exelon (TN); Rivastigmine (JAN/USAN/INN)

3-((1S)-1-(Dimethylamino) ethyl)phenyl N-ethyl-N-methylcarbamate

3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate

3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate

AB1004572

AC1L2U92

BAN

BIDD:GT0316

C11766

Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester

Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1); Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1); Carbamic acid,ethylm

Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-

Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester

Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

CHEMBL636

CID77991

D03822

DAP000149

DB00989

DNC013071

Ena 713 Free Base

ENA-713

ENA-713; SDZ-212-713; SDZ-ENA-713

ENA-713D

Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester

EXCELON

Exelon

Exelon MR

Exelon Patch

Exelon TDS

FDA

HMS2089H18

I06-2037

INN

LS-172571

LS-49755

m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

MFCD00871496

MFCD03700731

MolPort-003-666-662

N/A

NCGC00167531-01

ONO-2540

Prometax

QA-6265

Rivastach

Rivastigmine (BAN

Rivastigmine (FDA

Rivastigmine (JAN/USAN/INN)

Rivastigmine Hydrogen Tartrate

Rivastigmine Tartrate

Rivastigmine tartrate (Exelon)

Rivastigmine [USAN:INN]

RivastigmineHydrogenTartrate

SDZ 212-713

SDZ-212-713

SDZ-ENA-713

UNII-PKI06M3IW0

USAN); Rivastigmine Tartrate (FDA)

[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.28 8.58 -39.45 1 4 1 34 251.35 5

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 2.04e+00 g/l DrugBank-approved
Therapy acetylcholinesterase inhibitor SMDC Pharmakon
Target AChR Selleck Chemicals
Indications antidementia KeyOrganics Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ACES-10-E Acetylcholinesterase (cluster #10 Of 12), Eukaryotic Eukaryotes 2250 0.44 Binding ≤ 10μM
CHLE-1-E Butyrylcholinesterase (cluster #1 Of 7), Eukaryotic Eukaryotes 1600 0.45 Binding ≤ 10μM
Q9JKC1-1-E Butyrylcholinesterase (cluster #1 Of 1), Eukaryotic Eukaryotes 350 0.50 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
ACES_HUMAN P22303 Acetylcholinesterase, Human 37 0.58 Binding ≤ 1μM
CHLE_HUMAN P06276 Butyrylcholinesterase, Human 170 0.53 Binding ≤ 1μM
Q9JKC1_RAT Q9JKC1 Butyrylcholinesterase, Rat 350 0.50 Binding ≤ 1μM
CHLE_HORSE P81908 Cholinesterase, Horse 831.763771 0.47 Binding ≤ 1μM
ACES_RAT P37136 Acetylcholinesterase, Rat 1820 0.45 Binding ≤ 10μM
ACES_HUMAN P22303 Acetylcholinesterase, Human 1535 0.45 Binding ≤ 10μM
ACES_MOUSE P21836 Acetylcholinesterase, Mouse 5500 0.41 Binding ≤ 10μM
ACES_ELEEL O42275 Acetylcholinesterase, Eleel 4168.69383 0.42 Binding ≤ 10μM
Q9JKC1_RAT Q9JKC1 Butyrylcholinesterase, Rat 1410 0.46 Binding ≤ 10μM
CHLE_MOUSE Q03311 Butyrylcholinesterase, Mouse 1600 0.45 Binding ≤ 10μM
CHLE_HUMAN P06276 Butyrylcholinesterase, Human 170 0.53 Binding ≤ 10μM
CHLE_HORSE P81908 Cholinesterase, Horse 831.763771 0.47 Binding ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Neurotransmitter Clearance In The Synaptic Cleft
Synthesis of PC
Synthesis, secretion, and deacylation of Ghrelin

Analogs ( Draw Identity 99% 90% 80% 70% )